Fezolinetant Benefits Women Not Suited for Hormone Therapy

(MedPage Today) -- PHILADELPHIA -- Fezolinetant (Veozah) improved menopause-related vasomotor symptoms in women unsuited or unwilling to take hormone therapy, according to a pooled analysis of two phase III studies. The analysis of the SKYLIGHT...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news